<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39465692</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>40</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Diagnostic accuracy of rapid antigen tests for detection of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2: Direct evidence from prospective clinical settings.</ArticleTitle><Pagination><StartPage>e39995</StartPage><MedlinePgn>e39995</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39995</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000039995</ELocationID><Abstract><AbstractText>Despite widespread application during the coronavirus disease-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection using patient-performed rapid antigen tests (RATs) is limited, especially regarding the Delta and Omicron variants. Therefore, in this study, we evaluated the performance of RATs in identifying Delta and Omicron infections in self-test settings. In this multicenter clinical performance study conducted in Korea between November 2021 and February 2022, we included participants without prior diagnostic device experience. Using 2 RAT types, we compared the results with real-time reverse transcriptase-polymerase chain reaction testing, focusing on clinical sensitivity and specificity. Reverse transcriptase-polymerase chain reaction helped confirm 77 SARS-CoV-2 infections among 280 participants. RATs exhibited high positive agreement for Omicron detection but lower rates for Delta, especially among partially vaccinated individuals. This study provides direct evidence that RATs, originally developed for ancestral strains of SARS-CoV-2, effectively detect major variants such as Delta and Omicron in real patient/clinical settings. By confirming variant presence through sequencing, our research offers significant and novel insights into the performance of RATs, particularly in the context of breakthrough infections postvaccination, with precise data on vaccination status and timing obtained from government records.</AbstractText><CopyrightInformation>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Jongyoun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jongmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Mee Kyung</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Shinwon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Soon Ok</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jeong Eun</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mok</LastName><ForeName>Jeongha</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Mi-Hyun</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eom</LastName><ForeName>Jung Seop</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sunjoo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Gyeongsang National University College of Medicine, Gyeonsangnam-do, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeonsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kye-Hyung</ForeName><Initials>KH</Initials><Identifier Source="ORCID">0000-0001-9682-9654</Identifier><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NRF-2022R1F1A1065194</GrantID><Agency>National Research Foundation of Korea</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="Y">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087124" MajorTopicYN="N">COVID-19 Serological Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>8</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39465692</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000039995</ArticleId><ArticleId IdType="pii">00005792-202410040-00001</ArticleId><ArticleId IdType="pmc">PMC11460869</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Regan J, Flynn JP, Choudhary MC, et al. . Detection of the Omicron variant virus with the Abbott BinaxNow SARS-CoV-2 rapid antigen assay. Open Forum Infect Dis. 2022;9:ofac022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8842316</ArticleId><ArticleId IdType="pubmed">35169591</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanley S, Hamel DJ, Wolf ID, et al. . Limit of detection for rapid antigen testing of the SARS-CoV-2 Omicron and Delta variants of concern using live-virus culture. J Clin Microbiol. 2022;60:e0014022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9116160</ArticleId><ArticleId IdType="pubmed">35440165</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus (COVID-19) Update: December 28, 2021.
2021. https://web.archive.org/web/20211229220840/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-december-28-2021. Accessed January 23, 2023.</Citation></Reference><Reference><Citation>Drain PK. Rapid diagnostic testing for SARS-CoV-2. N Engl J Med. 2022;386:264–72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820190</ArticleId><ArticleId IdType="pubmed">34995029</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrom J, Marquez C, Pilarowski G, et al. . Comparison of SARS-CoV-2 reverse transcriptase polymerase chain reaction and BinaxNOW rapid antigen tests at a community site during an Omicron surge: a cross-sectional study. Ann Intern Med. 2022;175:682–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943844</ArticleId><ArticleId IdType="pubmed">35286144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn S, Jang J, Park SY, Yang S, Ryu B, Shin E. Outbreak report of COVID-19 during designation of class 1 infectious disease in the Republic of Korea (January 20, 2020 and April 24, 2022). Public Health Wkly Rep. 2022;15:1759–72.</Citation></Reference><Reference><Citation>Lee SH. A routine sanger sequencing target specific mutation assay for SARS-CoV-2 variants of concern and interest. Viruses. 2021;13:2386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8706074</ArticleId><ArticleId IdType="pubmed">34960655</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni A, Herbert C, Lin H, et al. . Performance of rapid antigen tests to detect symptomatic and asymptomatic SARS-CoV-2 infection: a prospective Cohort study. Ann Intern Med. 2023;176:975–82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10321467</ArticleId><ArticleId IdType="pubmed">37399548</ArticleId></ArticleIdList></Reference><Reference><Citation>Venekamp RP, Schuit E, Hooft L, et al. . Diagnostic accuracy of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the Omicron period: a cross-sectional study. Clin Microbiol Infect. 2023;29:391.e1–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9659357</ArticleId><ArticleId IdType="pubmed">36379401</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand A, Vialard F, Esmail A, et al. . Self-tests for COVID-19: what is the evidence? A living systematic review and meta-analysis (2020–2023). PLOS Glob Public Health. 2024;4:e0002336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10849237</ArticleId><ArticleId IdType="pubmed">38324519</ArticleId></ArticleIdList></Reference><Reference><Citation>Viloria Winnett A, Akana R, Shelby N, et al. . Daily SARS-CoV-2 nasal antigen tests miss infected and presumably infectious people due to viral load differences among specimen types. Microbiol Spectr. 2023;11:e0129523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10434058</ArticleId><ArticleId IdType="pubmed">37314333</ArticleId></ArticleIdList></Reference><Reference><Citation>Drain PK, Bemer M, Morton JF, et al. . Accuracy of 2 rapid antigen tests during 3 phases of SARS-CoV-2 variants. JAMA Netw Open. 2022;5:e2228143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9403778</ArticleId><ArticleId IdType="pubmed">36001317</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>